Nokia Solutions and Networks Oy

Lifearc

Suzhou Yabao Pharmaceutical R&d Co., Ltd.

Weipeng (suzhou) Medical Devices Co., Ltd.

Yan Xia

Lin Zhu

Edward Giles Mciver

Ling Wu

Bin Yang

Yuanyuan Xu

Justin Stephen Bryans

Rui Li

Chunjun Chu

Hua Cai

Yang Song

Miao Liu

The heat dissipation component includes a heat conductor attached to the pluggable module or a heat sink associated with an interface of an electrical device and configured to conduct heat from the pluggable module to a heat sink, the heat conductor including the heat input section configured to be in thermal contact with the pluggable module; and a heat output section configured to be in thermal contact with the heat sink; and an elastic assembly coupled to the heat conductor and configured to, at least when the pluggable module is coupled to the interface, apply biasing forces to press the heat input section to the pluggable module and to press the heat output section to the heat sink.

Heat dissipation component and associated electrical device

A coherent anti-Stokes Raman scattering microscope imaging apparatus, comprising: a laser light source (), a two-dimensional oscillating mirror assembly (), a first light dichroic mirror plate (), an objective lens (), a sample translation platform (), a collection device (), and a data processing module; the laser light source () is used for producing a first laser beam and a second laser beam; the first laser beam and the second laser beam are coaxially emitted and are incident on the two-dimensional oscillating mirror assembly (); the first laser beam and the second laser beam leaving the two-dimensional oscillating mirror assembly pass through the first light dichroic mirror plate () and the objective lens (); the objective lens () focuses the first laser beam and the second laser beam onto the sample translation platform; the signal light produced on the sample translation platform () passes through the objective lens ().

Coherent anti-Stokes Raman scattering microscope imaging apparatus

Provided are a substituted tricyclic heterocyclic compound of formula I or a stereoisomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt, ester or a prodrug thereof, a pharmaceutical composition including the same and uses thereof. The substituted tricyclic heterocyclic compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be used for treating a disorder caused by at least one of cancer and neurodegenerative diseases. Further the compounds and the pharmaceutical compositions comprising the compounds disclosed herein can be also used for preventing or treating a disorder caused by, associated with or accompanied by any abnormal kinase activity. 

Substituted tricyclic heterocyclic compounds and use thereof

Growing community of inventors

Jiangsu, China

Yan Xia